Select a community
MS
Find out more about the PatientsLikeMe
MS Community
Home > Community Treatment Reports > Desvenlafaxine Treatment Report
What is Desvenlafaxine?

Desvenlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI). It is an extended release formulation believed to treat depression by affecting the levels of serotonin and norepinephrine, two neurotransmitters associated with depression.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Depression 22 5
Other 2 2
Mood swings 2 1
Pain 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
4 67%
Moderate
0 0%
Mild
2 33%
None
0 0%

Most commonly reported side effects

Sedation
3 50%
constant crying episodes
1 17%
Problems with coordination
1 17%
drunk feeling
1 17%
Depression with suicidal thoughts
1 17%
nausea, dizziness
1 17%
  • Mild
  • Moderate
  • Severe

Dosages

  1 other daily 50 mg daily 100 mg daily 150 mg daily
  1 Number of Patients: 1 11 Number of Patients: 11 4 Number of Patients: 4 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Desvenlafaxine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe
7 64% Side effects too severe: 64%
Did not seem to work
4 36% Did not seem to work: 36%
Expense
2 18% Expense: 18%
Doctor's advice
2 18% Doctor's advice: 18%
Personal research
1 9% Personal research: 9%
Other
1 9% Other: 9%

See all 11 patients who’ve stopped taking Desvenlafaxine

Currently Taking Desvenlafaxine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
2
1
9
2
0

Stopped Taking Desvenlafaxine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
3
3
4
1
0
0

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
6 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
2 33%
Somewhat
0 0%
A little
1 17%
Not at all
3 50%

Cost

Paid out of pocket

$200+
1 17%
$100-199
0 0%
$50-99
0 0%
$25-49
3 50%
< $25
1 17%

Report created on November 21, 2009.